Cleansing System Facilitates Colonoscopy Bowel Preparation
By HospiMedica International staff writers Posted on 24 Jun 2019 |
Image: The Pure-Vu GEN2 colon cleansing system (Photo courtesy of Motus GI).
A new device enables the safe and rapid cleansing of a poorly prepared colon during the colonoscopy procedure, while preserving established procedural workflow and techniques.
The Motus GI (Fort Lauderdale, FL, USA) Pure-Vu GEN2 colon cleansing system is designed to generate a pulsed vortex mixture of water and air that can safely remove debris from the colon mucosa while simultaneously evacuating bowel contents, clearing the way for endoscopists to perform a quality examination, even when the patient does not want to, or is not capable of, completing a successful colon prep on their own. Pure-Vu integrates easily with most standard and slim endoscopes, and fits easily into the clinical workflow.
The system includes a control unit with sensing technology that prevents clogging during evacuation, a foot pedal for activation, and the disposable Pure-Vu Sleeve, with multiple irrigation jets spaced on the rim perimeter to efficiently clean the mucosal surface and two evacuation ports to increase removal of colon content. A low friction hydrophilic coating aids smooth advancement of the sleeve into the colon. In clinical studies, the system significantly increased the number of patients with an adequate cleansing level, based on the Boston Bowel Preparation Scale Score, a validated assessment instrument.
“The Pure-Vu System continues to demonstrate outstanding cleansing performance in poorly prepped colons, including the statistically significant improvement in colon cleanliness in hospitalized patients, as recently demonstrated,” said Tim Moran, CEO of Motus GI, commenting on FDA approval of the system. “We are now well positioned to execute our planned commercial launch of the Pure-Vu System this year and advance toward our goal of establishing the Pure-Vu System as a new standard of care in key endoscopy segments.”
“Inadequate bowel preparation prior to colonoscopy remains an unmet need that affects a significant percentage of patients’ ability to receive a complete and high-quality exam. This often leads to canceled, delayed and aborted procedures, resulting in prolonged hospitalizations and increased costs for both patients and providers,” said gastroenterologist Jason Samarasena, MD, of the University of California Irvine (UCI; USA). “The Pure-Vu System provides an important solution to address the significant clinical challenges and inefficiencies associated with inadequate prep.”
Challenges with bowel preparation for inpatient colonoscopy represent a significant area of unmet need that directly affects clinical outcomes and increases the cost of care in a market segment that comprises approximately 1.5 million annual procedures in the United States, and approximately four million annual procedures worldwide.
Related Links:
Motus GI
The Motus GI (Fort Lauderdale, FL, USA) Pure-Vu GEN2 colon cleansing system is designed to generate a pulsed vortex mixture of water and air that can safely remove debris from the colon mucosa while simultaneously evacuating bowel contents, clearing the way for endoscopists to perform a quality examination, even when the patient does not want to, or is not capable of, completing a successful colon prep on their own. Pure-Vu integrates easily with most standard and slim endoscopes, and fits easily into the clinical workflow.
The system includes a control unit with sensing technology that prevents clogging during evacuation, a foot pedal for activation, and the disposable Pure-Vu Sleeve, with multiple irrigation jets spaced on the rim perimeter to efficiently clean the mucosal surface and two evacuation ports to increase removal of colon content. A low friction hydrophilic coating aids smooth advancement of the sleeve into the colon. In clinical studies, the system significantly increased the number of patients with an adequate cleansing level, based on the Boston Bowel Preparation Scale Score, a validated assessment instrument.
“The Pure-Vu System continues to demonstrate outstanding cleansing performance in poorly prepped colons, including the statistically significant improvement in colon cleanliness in hospitalized patients, as recently demonstrated,” said Tim Moran, CEO of Motus GI, commenting on FDA approval of the system. “We are now well positioned to execute our planned commercial launch of the Pure-Vu System this year and advance toward our goal of establishing the Pure-Vu System as a new standard of care in key endoscopy segments.”
“Inadequate bowel preparation prior to colonoscopy remains an unmet need that affects a significant percentage of patients’ ability to receive a complete and high-quality exam. This often leads to canceled, delayed and aborted procedures, resulting in prolonged hospitalizations and increased costs for both patients and providers,” said gastroenterologist Jason Samarasena, MD, of the University of California Irvine (UCI; USA). “The Pure-Vu System provides an important solution to address the significant clinical challenges and inefficiencies associated with inadequate prep.”
Challenges with bowel preparation for inpatient colonoscopy represent a significant area of unmet need that directly affects clinical outcomes and increases the cost of care in a market segment that comprises approximately 1.5 million annual procedures in the United States, and approximately four million annual procedures worldwide.
Related Links:
Motus GI
Latest Critical Care News
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events
- AI Diagnostic Tool Guides Rapid Diagnosis and Prediction of Sepsis
- World's First AI-Powered Sepsis Alert System Detects Sepsis in One Minute
- Smartphone Magnetometer Uses Magnetized Hydrogel to Measure Biomarkers for Disease Diagnosis
- New Technology to Revolutionize Valvular Heart Disease Care